N-methyl-D-aspartate receptor-dependent denitrosylation of neuronal nitric oxide synthase increase the enzyme activity. 2012

Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
Research Center of Biochemistry and Molecular Biology; Jiangsu Key Laboratory of Brain Disease Bioinformation, Xuzhou Medical College, Xuzhou, Jiangsu, People's Republic of China.

Our laboratory once reported that neuronal nitric oxide synthase (nNOS) S-nitrosylation was decreased in rat hippocampus during cerebral ischemia-reperfusion, but the underlying mechanism was unclear. In this study, we show that nNOS activity is dynamically regulated by S-nitrosylation. We found that overexpressed nNOS in HEK293 (human embryonic kidney) cells could be S-nitrosylated by exogenous NO donor GSNO and which is associated with the enzyme activity decrease. Cys(331), one of the zinc-tetrathiolate cysteines, was identified as the key site of nNOS S-nitrosylation. In addition, we also found that nNOS is highly S-nitrosylated in resting rat hippocampal neurons and the enzyme undergos denitrosylation during the process of rat brain ischemia/reperfusion. Intrestingly, the process of nNOS denitrosylation is coupling with the decrease of nNOS phosphorylation at Ser(847), a site associated with nNOS activation. Further more, we document that nNOS denitrosylation could be suppressed by pretreatment of neurons with MK801, an antagonist of NMDAR, GSNO, EGTA, BAPTA, W-7, an inhibitor of calmodulin as well as TrxR1 antisense oligonucleotide (AS-ODN) respectively. Taken together, our data demonstrate that the denitrosylation of nNOS induced by calcium ion influx is a NMDAR-dependent process during the early stage of ischemia/reperfusion, which is majorly mediated by thioredoxin-1 (Trx1) system. nNOS dephosphorylation may be induced by the enzyme denitrosylation, which suggest that S-nitrosylation/denitrosylation of nNOS may be an important mechanism in regulating the enzyme activity.

UI MeSH Term Description Entries
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D003553 Cystine A covalently linked dimeric nonessential amino acid formed by the oxidation of CYSTEINE. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Copper Cystinate,L-Cystine,L Cystine
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
April 2004, The Journal of biological chemistry,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
January 2010, Molecular medicine (Cambridge, Mass.),
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
February 2004, Toxicology and applied pharmacology,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
August 2012, The Journal of pharmacology and experimental therapeutics,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
May 1994, Proceedings of the National Academy of Sciences of the United States of America,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
January 2009, Pharmacological reports : PR,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
May 1998, Proceedings of the National Academy of Sciences of the United States of America,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
January 1993, Biochemical pharmacology,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
January 2000, Neurotoxicology and teratology,
Zhong-Wei Qu, and Wan-Ying Miao, and Shu-Qun Hu, and Chong Li, and Xing-Li Zhuo, and Yan-Yan Zong, and Yong-Ping Wu, and Guang-Yi Zhang
January 2012, British journal of anaesthesia,
Copied contents to your clipboard!